Table 2 Kinetic parameters of DUSP3, DUSP13B, and DUSP14 for
catalysis of SfBP and DiFMUP at pH 6
PTP activity. Due to its unparalleled selectivity, short detec-
tion time, over 90-fold signal enhancement, and the applic-
ability to high throughput screening (HTS), SfBP-based assays
could be a promising tool for the discovery of specific VHR
inhibitors for the identification of therapeutic agents for VHR-
related diseases, e.g., prostate and cervical cancers. The X-ray
structural analysis and development of an SfBP-based selec-
tive inhibitor for VHR are currently being investigated and
will be reported in due course.
Enzyme Km
Substrate (nM)
kcat
kcat/Km
(minꢁ1 mMꢁ1
)
Enzyme
(mM) (minꢁ1
)
DUSP3
(VHR)
DUSP14
SfBP 10
34.5 159.36
39.1 408.64
4.62
10.45
0.36
1.25
0.01
0.49
DiFMUP 0.2
SfBP 100
DiFMUP 1.0
DUSP13B SfBP 2800
DiFMUP 25
18.2
48.5
71.3
6.53
60.54
0.73
302.4 147.98
This study was supported by National Research Foundation
of Korea (NRF) grants (NRF-2011-355-C00047), the WCU
program (NRF-2009-0078236), the Biosignal Analysis Techno-
logy Innovation Program (2011-0027722), and the Bio &
Medical Technology Development Program (2011-0019464)
funded by the Korean Ministry of Education, Science, and
Technology (MEST).
negligible selectivity for neither classical nor dual-specific
PTPs. In contrast, we observed a good selectivity of SfBP
toward VHR, also known as a dual-specific PTP-3 (DUSP3),
in the initial screening and its excellent selectivity at the lower
concentration (0.1 mM) of selected DUSPs and at pH 8.0
(see the inset of Fig. 3). Although catalytic activities of DUSPs
were higher at pH 6, known as optimal pH for DUSPs,14 than
at pH 8, the selectivity was conserved at both pH values
(see Fig. S5, ESIw). Since DUSP13B and DUSP14 showed
meaningful catalytic activities to SfBP, especially at pH 6, their
substrate specificity was determined using Lineweaver–Burk
analysis and compared with that of DUSP3. Substrate speci-
Notes and references
1 (a) T. Hunter, Cell, 1995, 80, 225–236; (b) N. K. Tonks, Nat. Rev.
Mol. Cell Biol., 2006, 7, 833–846; (c) J. A. Ubersax and J. E. Ferrell Jr.,
Nat. Rev. Mol. Cell Biol., 2007, 8, 530–541.
2 Z. Zhang, Curr. Opin. Chem. Biol., 2001, 5, 416–423.
3 T. O. Johnson, J. Ermolieff and M. R. Jirousek, Nat. Rev. Drug
Discovery, 2002, 1, 696–709.
ficity of DUSP3 to SfBP at pH 6 (kcat/Km = 4.62 minꢁ1 mMꢁ1
)
was increased by 231 times from that at pH 8, and was 462-
and 13-times higher than those of DUSP13B and DUSP14,
respectively, at pH 6 (Table 2). Interestingly, the substrate
specificity of SfBP toward three PTPs was dictated by the
turnover number (kcat) rather than binding affinity (Km).
While the Km values are within 4-fold difference, the kcat
values showed up to 218-fold difference among three enzymes
(Table 2), which indicates that SfBP binds to DUSP3 in proper
orientation with proximity for its catalytic activity, but not to
DUSP14 and DUSP13B.
4 E. H. Fischer, H. Charbonneau and N. K. Tonks, Science, 1991,
253, 401–406.
5 L. Tautz and T. Mustelin, Methods, 2007, 42, 250–260.
6 (a) A. E. Stewart, S. Dowd, S. M. Keyse and N. Q. McDonald,
Nat. Struct. Biol., 1999, 6, 174–181; (b) T. Yokota, Y. Nara,
A. Kashima, K. Matsubara, S. Misawa, R. Kato and S. Sugio,
Proteins: Struct., Funct., Genet., 2007, 66, 272–278.
7 (a) T.-I. Kim, H. J. Kang, G. Han, S. J. Chung and Y. Kim, Chem.
Commun., 2009, 5895–5897; (b) T.-I. Kim, M. S. Jeong, S. J. Chung
and Y. Kim, Chem.–Eur. J., 2010, 16, 5297–5300.
8 (a) E. Kim, M. Koh, J. Ryu and S. B. Park, J. Am. Chem. Soc.,
2008, 130, 12206–12207; (b) E. Kim, M. Koh, B. J. Lim and
S. B. Park, J. Am. Chem. Soc., 2011, 133, 6642–6649.
9 (a) E. Kim, S. Lee and S. B. Park, Chem. Commun., 2011, 47,
7734–7736; (b) E. Kim, S. Lee and S. B. Park, Chem. Commun.,
2012, 48, 2331–2333.
Using in silico analysis, we proposed a plausible explanation
of this selectivity of SfBP with a good docking score at the
active site of VHR, which has a relatively shallow pocket. In
contrast, the active sites of classical PTPs contain a deep and
narrow pocket, where SfBP cannot be accommodated due to
the presence of the bulky indolizine heterocycle at the para
position of the phosphate group, thereby making itself a poor
substrate for classical PTPs (see ESIw). Although the selecti-
vity of SfBP toward VHR among 35 dual-specific PTPs is not
yet fully addressed, this notable selectivity of SfBP toward
VHR might be caused by the drug-like indolizine core
skeleton,17 which implies that pharmacophore-embedded
fluorescent compounds18 could function as powerful research
tools for providing valuable information about players in the
proteomic arena to elucidate complicated cellular processes. In
fact, VHR has been recognized as a biomarker for various
cancers including prostate15 and cervical cancers.16 Therefore,
we envision that the VHR-specific fluorescent bioprobe, SfBP,
can provide new insight into the design of potential therapeutics
for prostate and cervical cancers.
10 H. Kobayashi, M. Ogawa, R. Alford, P. L. Choyke and Y. Urano,
Chem. Rev., 2010, 110, 2620–2640.
11 (a) J. Bermudez, C. S. Fake, G. F. Joiner, K. A. Joiner, F. D. King,
W. D. Miner and G. J. Sanger, J. Med. Chem., 1990, 33,
1924–1929; (b) S. Hagishita, M. Yamada, K. Shirahase,
T. Okada, Y. Murakami, Y. Ito, T. Matsuura, M. Wada,
T. Kato, M. Ueno, Y. Chikazawa, K. Yamada, T. Ono,
I. Teshirogi and M. Ohtani, J. Med. Chem., 1996, 39,
3636–3658.
12 A. Skowronska, M. Pakulski, J. Michalski, D. Cooper and
S. Trippett, Tetrahedron Lett., 1980, 21, 321–322.
13 L. D. Lavis and R. T. Raines, ACS Chem. Biol., 2008, 3,
142–155.
14 S. Wu, S. Vossius, S. Rahmouni, A. V. Miletic, T. Vang,
J. Vazquez-Rodriguez, F. Cerignoli, Y. Arimura, S. Williams,
T. Hayes, M. Moutschen, S. Vasile, M. Pellecchia, T. Mustelin
and L. Tautz, J. Med. Chem., 2009, 52, 6716–6723.
15 S. Rahmouni, F. Cerignoli, A. Alonso, T. Tsutji, R. Henkens,
C. Zhu, C. Louis-dit-Sully, M. Moutschen, W. Jiang and
T. Mustelin, Nat. Cell Biol., 2006, 8, 524–531.
16 R. Henkens, P. Delvenne, M. Arafa, M. Moutschen, M. Zeddou,
L. Tautz, J. Boniver, T. Mustelin and S. Rahmouni, BMC Cancer,
2008, 8, 147.
17 T. Weide, L. Arve, H. Prinz, H. Waldmann and H. Kessler, Bioorg.
Med. Chem. Lett., 2006, 16, 59–63.
In summary, we have developed a new fluorescent bioprobe
that is selective for a specific PTP, VHR (DUSP3), among 30
classical and 35 dual-specific PTPs, using a PeT-based turn
on–off mechanism upon dephosphorylation caused by the
18 O. N. Burchak, L. Mugherli, M. Ostuni, J. J. Lacapere and
M. Y. Balakirev, J. Am. Chem. Soc., 2011, 133, 10058–10061.
c
This journal is The Royal Society of Chemistry 2012
Chem. Commun., 2012, 48, 6553–6555 6555